“…Although from this retrospective analysis it appeared that the addition of ATT to topical therapy does not significantly affect the treatment outcome of TAU patients, different single centers studies reported a therapeutic role of ATT in patients with TAU. 2,6,23,24,[26][27][28][29][30][31][32][33][34][35][36][37][38][39] In addition, from COTS consensus guidelines (unpublished data) it emerged that experts are keen to start ATT in TAU in case of recurrent episodes in patients with one immunological evidence of TB, together with radiological findings suggestive of active or healed pulmonary TB, irrespective of patient's endemicity. In case of first episode of TAU, experts are inclined to initiate ATT in patients with both immunological and radiological tests positive, coming from both endemic and non endemic region.…”